世界の癲癇診断・治療市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV11874)
◆英語タイトル:Global Epilepsy Diagnosis & Treatment Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV11874
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:91
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは癲癇診断・治療の世界市場について調査・分析した資料です。種類別(診断(神経学的検査・血液検査・画像診断)、治療(医学・手術))の市場規模、用途別(病院、クリニック)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別癲癇診断・治療の競争状況、市場シェア
・世界の癲癇診断・治療市場:種類別市場規模 2015年-2020年(診断(神経学的検査・血液検査・画像診断)、治療(医学・手術))
・世界の癲癇診断・治療市場:種類別市場規模予測 2021年-2026年(診断(神経学的検査・血液検査・画像診断)、治療(医学・手術))
・世界の癲癇診断・治療市場:用途別市場規模 2015年-2020年(病院、クリニック)
・世界の癲癇診断・治療市場:用途別市場規模予測 2021年-2026年(病院、クリニック)
・北米の癲癇診断・治療市場分析:米国、カナダ
・ヨーロッパの癲癇診断・治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの癲癇診断・治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の癲癇診断・治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの癲癇診断・治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer、Johnson & Johnson、UCB Pharma、Abbott、GlaxoSmithKline、Novartis、Sanofi、Takeda、Medtronic、Natus Medical、Siemens
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the arms and legs, and others are some of the common symptoms of the disease.
Increasing prevalence of epilepsy is a major driver for the market. According to a report by the World Health Organization (2018), about 50 million people across the world are estimated to suffer from epilepsy, making it one of the most common neurological diseases. In addition, the report states that the total number of people aged 65 or more is projected to increase from 524 million in 2010 to approximately 1.5 billion by 2050.

Market Analysis and Insights: Global Epilepsy Diagnosis & Treatment Market
The global Epilepsy Diagnosis & Treatment market size is projected to reach US$ 9065.6 million by 2026, from US$ 7778.7 million in 2020, at a CAGR of 15.0%% during 2021-2026.

Global Epilepsy Diagnosis & Treatment Scope and Market Size
Epilepsy Diagnosis & Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epilepsy Diagnosis & Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Johnson & Johnson
UCB Pharma
Abbott
GlaxoSmithKline
Novartis
Sanofi
Takeda
Medtronic
Natus Medical
Siemens

Market segment by Type, the product can be split into
Diagnosis (Neurological Exam, Blood Test, Imaging)
Treatment (Medication, Surgery)
Market segment by Application, split into
Hospitals
Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Epilepsy Diagnosis & Treatment Revenue
1.4 Market by Type
1.4.1 Global Epilepsy Diagnosis & Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnosis (Neurological Exam, Blood Test, Imaging)
1.4.3 Treatment (Medication, Surgery)
1.5 Market by Application
1.5.1 Global Epilepsy Diagnosis & Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Epilepsy Diagnosis & Treatment Market Perspective (2015-2026)
2.2 Global Epilepsy Diagnosis & Treatment Growth Trends by Regions
2.2.1 Epilepsy Diagnosis & Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Epilepsy Diagnosis & Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Epilepsy Diagnosis & Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Epilepsy Diagnosis & Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Epilepsy Diagnosis & Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Epilepsy Diagnosis & Treatment Players by Market Size
3.1.1 Global Top Epilepsy Diagnosis & Treatment Players by Revenue (2015-2020)
3.1.2 Global Epilepsy Diagnosis & Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Epilepsy Diagnosis & Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Epilepsy Diagnosis & Treatment Market Concentration Ratio
3.2.1 Global Epilepsy Diagnosis & Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Epilepsy Diagnosis & Treatment Revenue in 2019
3.3 Epilepsy Diagnosis & Treatment Key Players Head office and Area Served
3.4 Key Players Epilepsy Diagnosis & Treatment Product Solution and Service
3.5 Date of Enter into Epilepsy Diagnosis & Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Epilepsy Diagnosis & Treatment Historic Market Size by Type (2015-2020)
4.2 Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)
5.2 Global Epilepsy Diagnosis & Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Epilepsy Diagnosis & Treatment Market Size (2015-2020)
6.2 Epilepsy Diagnosis & Treatment Key Players in North America (2019-2020)
6.3 North America Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
6.4 North America Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Epilepsy Diagnosis & Treatment Market Size (2015-2020)
7.2 Epilepsy Diagnosis & Treatment Key Players in Europe (2019-2020)
7.3 Europe Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
7.4 Europe Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)

8 China
8.1 China Epilepsy Diagnosis & Treatment Market Size (2015-2020)
8.2 Epilepsy Diagnosis & Treatment Key Players in China (2019-2020)
8.3 China Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
8.4 China Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Epilepsy Diagnosis & Treatment Market Size (2015-2020)
9.2 Epilepsy Diagnosis & Treatment Key Players in Japan (2019-2020)
9.3 Japan Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
9.4 Japan Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Epilepsy Diagnosis & Treatment Market Size (2015-2020)
10.2 Epilepsy Diagnosis & Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)

11 India
11.1 India Epilepsy Diagnosis & Treatment Market Size (2015-2020)
11.2 Epilepsy Diagnosis & Treatment Key Players in India (2019-2020)
11.3 India Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
11.4 India Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Epilepsy Diagnosis & Treatment Market Size (2015-2020)
12.2 Epilepsy Diagnosis & Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Epilepsy Diagnosis & Treatment Market Size by Type (2015-2020)
12.4 Central & South America Epilepsy Diagnosis & Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Epilepsy Diagnosis & Treatment Introduction
13.1.4 Pfizer Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Epilepsy Diagnosis & Treatment Introduction
13.2.4 Johnson & Johnson Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 UCB Pharma
13.3.1 UCB Pharma Company Details
13.3.2 UCB Pharma Business Overview
13.3.3 UCB Pharma Epilepsy Diagnosis & Treatment Introduction
13.3.4 UCB Pharma Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.3.5 UCB Pharma Recent Development
13.4 Abbott
13.4.1 Abbott Company Details
13.4.2 Abbott Business Overview
13.4.3 Abbott Epilepsy Diagnosis & Treatment Introduction
13.4.4 Abbott Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.4.5 Abbott Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Epilepsy Diagnosis & Treatment Introduction
13.5.4 GlaxoSmithKline Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview
13.6.3 Novartis Epilepsy Diagnosis & Treatment Introduction
13.6.4 Novartis Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Epilepsy Diagnosis & Treatment Introduction
13.7.4 Sanofi Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Takeda
13.8.1 Takeda Company Details
13.8.2 Takeda Business Overview
13.8.3 Takeda Epilepsy Diagnosis & Treatment Introduction
13.8.4 Takeda Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.8.5 Takeda Recent Development
13.9 Medtronic
13.9.1 Medtronic Company Details
13.9.2 Medtronic Business Overview
13.9.3 Medtronic Epilepsy Diagnosis & Treatment Introduction
13.9.4 Medtronic Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.9.5 Medtronic Recent Development
13.10 Natus Medical
13.10.1 Natus Medical Company Details
13.10.2 Natus Medical Business Overview
13.10.3 Natus Medical Epilepsy Diagnosis & Treatment Introduction
13.10.4 Natus Medical Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
13.10.5 Natus Medical Recent Development
13.11 Siemens
10.11.1 Siemens Company Details
10.11.2 Siemens Business Overview
10.11.3 Siemens Epilepsy Diagnosis & Treatment Introduction
10.11.4 Siemens Revenue in Epilepsy Diagnosis & Treatment Business (2015-2020)
10.11.5 Siemens Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Pfizer、Johnson & Johnson、UCB Pharma、Abbott、GlaxoSmithKline、Novartis、Sanofi、Takeda、Medtronic、Natus Medical、Siemens

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の癲癇診断・治療市場2026:インサイト・予測(Global Epilepsy Diagnosis & Treatment Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。